Pfizer

  • Prevnar 13 2015 report

    Prevnar 13 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by...

  • Pristiq 2015 report

    Pristiq 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...

  • Quillivant XR 2015 report

    Quillivant XR 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by...

  • Rebif 2015 report

    Rebif 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 18 Pages The 5 Key Questions Addressed by this...

  • Relpax 2015 report

    Relpax 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Somavert 2015 report

    Somavert 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this...

  • Sutent 2015 report

    Sutent 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Thrombin 2015 report

    Thrombin 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 37 Pages The 5 Key Questions Addressed by this...

  • Torisel 2015 report

    Torisel 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Toviaz 2015 report

    Toviaz 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Trumenba 2015 report

    Trumenba 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Viagra 2015 report

    Viagra 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 25 Pages The 5 Key Questions Addressed by this...